A share price of West Pharmaceutical Services, Inc [WST] is currently trading at $229.23, up 1.35%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The WST shares have gain 3.62% over the last week, with a monthly amount glided 2.44%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
West Pharmaceutical Services, Inc [NYSE: WST] stock has seen the most recent analyst activity on June 24, 2025, when Barclays initiated its Equal Weight rating and assigned the stock a price target of $245. Previously, Evercore ISI started tracking the stock with Outperform rating on March 18, 2025, and set its price target to $275. On February 14, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $250 on the stock. Citigroup started tracking the stock assigning a Buy rating and suggested a price target of $400 on January 08, 2025. Wolfe Research initiated its recommendation with a Peer Perform. UBS upgraded its rating to Buy for this stock on December 12, 2024, and upped its price target to $390. In a note dated February 07, 2024, Jefferies upgraded an Buy rating on this stock and boosted its target price from $323 to $536.
West Pharmaceutical Services, Inc experienced fluctuations in its stock price throughout the past year between $187.43 and $352.33. Currently, Wall Street analysts expect the stock to reach $245 within the next 12 months. West Pharmaceutical Services, Inc [NYSE: WST] shares were valued at $229.23 at the most recent close of the market. An investor can expect a potential return of 6.88% based on the average WST price forecast.
Analyzing the WST fundamentals
Trailing Twelve Months sales for West Pharmaceutical Services, Inc [NYSE:WST] were 2.90B which represents 0.42% growth. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at 0.19%, Pretax Profit Margin comes in at 0.2%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.17 and Total Capital is 0.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 225.51 points at the first support level, and at 221.80 for the second support level. However, for the 1st resistance point, the stock is sitting at 233.39, and for the 2nd resistance point, it is at 237.56.
Ratios To Look Out For
To put it in perspective, the Current Ratio for West Pharmaceutical Services, Inc [NYSE:WST] is 2.77. Also, the Quick Ratio is 2.03, while the Cash Ratio stands at 0.77. Considering the valuation of this stock, the price to sales ratio is 5.69, the price to book ratio is 6.13 and price to earnings (TTM) ratio is 36.00.
Transactions by insiders
Recent insider trading involved Witherspoon Charles, VP & Treasurer, that happened on Oct 29 ’24 when 703.0 shares were sold. VP & Treasurer, Witherspoon Charles completed a deal on Aug 19 ’24 to sell 1029.0 shares. Meanwhile, President, CEO and Board Chair Green Eric Mark sold 30732.0 shares on Aug 06 ’24.
